Skip to main content
BrainCited

Vitamin D for Nutritional Deficiency Cognitive Impairment

B

Vitamin D deficiency is identified as a critical risk factor for cognitive decline. 40% of geriatric memory clinic patients are D-deficient. Co-supplementation with B12 and folate appears to provide synergistic cognitive support.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dnutritional\u002Ddeficiency\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

The Bottom Line

Vitamin D deficiency is identified as a critical risk factor for cognitive decline. 40% of geriatric memory clinic patients are D-deficient. Co-supplementation with B12 and folate appears to provide synergistic cognitive support.

Key Study Findings

Observational Study n=2582
Relationship Between Serum Vitamins and Cognitive Impairment in the Elderly: A Study Based on the …
Dose: None vs: None Outcome: Cognitive impairment risk Effect: OR=0.695 (Vit D); OR=0.777 (FA) p=0.003 (Vit D); p=0.034 (FA)

Population: Elderly participants aged 60+ from NHANES 2011-2014

Review
B-vitamins and one-carbon metabolism during pregnancy: health impacts and challenges.
Dose: None vs: None Outcome: Pregnancy outcomes and offspring neurodevelopment Effect: None None

Population: Pregnant women (review)

Meta-Analysis
Effects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild …
Dose: None vs: Control Outcome: Cognitive function Effect: SMD = 0.58, 95% CI = [0.20, 0.96] P = 0.003

Population: Patients with mild cognitive impairment

Other
Dietary Clostridium butyricum and 25-Hydroxyvitamin D3 modulate bone metabolism of broilers through the gut-brain axis.
Dose: 75 mg vs: None Outcome: Body weight Effect: None P < 0.05

Population: Rat model

Controlled Clinical Trial
Targeting neuroendocrine abnormalities in Parkinson's disease with exercise.
Dose: None vs: None Outcome: neuroprotection Effect: None None

Population: None

RCT n=65 36 weeks Double-blind
Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: …
Dose: 4 capsules daily, each containing: beta-glucan 250 mg + vitamin D3 3.75 µg + vitamin B6 1.05 mg + zi vs: Placebo Effect: significant improvement in cognitive fatigue (FIS-40); p = 0.0338 0.0338

Key Statistics

20

Studies

4500

Participants

Positive

B

Grade

Referenced Papers

European journal of … 2012 225 citations
Evidence report/technology assessment 2006

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
600-2,000 IU/day
deficiencycorrection:
4,000-5,000 IU/day

Upper limit: 4,000 IU/day (IOM); 10,000 IU/day (Endocrine Society upper safety)

Dosages Studied in Research

Dosage Duration Effect N
None -- Positive 2582
None -- Positive --
None -- Positive --
75 mg -- Neutral --
None -- Positive --
4 capsules daily, each containing: beta-glucan 250 mg + vitamin D3 3.75 µg + vitamin B6 1.05 mg + zi 36 weeks Positive 65
None -- Negative 90
50000 IU/week 9 weeks Positive 619

Best taken: With meals containing fat; morning preferred

Safety & Side Effects

Reported Side Effects

  • Hypercalcemia at very high doses
  • Nausea and vomiting
  • Kidney stones (rare, high doses)
  • Weakness and fatigue

Known Interactions

  • Corticosteroids (reduce calcium absorption)
  • Statins (both affect cholesterol pathways)
  • Thiazide diuretics (additive calcium retention)
  • Weight loss drugs (may reduce vitamin D absorption)

Tolerable upper intake: 4,000 IU/day (IOM); 10,000 IU/day (Endocrine Society upper safety)

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Vitamin D help with Nutritional Deficiency Cognitive Impairment?
Based on 20 studies with 4,500 participants, there is moderate evidence from clinical studies that Vitamin D may support Nutritional Deficiency Cognitive Impairment management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Nutritional Deficiency Cognitive Impairment?
Studies have used various dosages. A commonly studied range is 600-2,000 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses, Nausea and vomiting, Kidney stones (rare, high doses), Weakness and fatigue. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Nutritional Deficiency Cognitive Impairment?
We rate the evidence as Grade B (Good Evidence). This rating is based on 20 peer-reviewed studies with 4,500 total participants. The overall direction of effect is positive.

Related Evidence

Other ingredients for Nutritional Deficiency Cognitive Impairment

Vitamin D for other conditions

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.